{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0000", "char_start": 0, "char_end": 1200, "pages": [1], "text": "April 2024\nVolume 40 | Number 4\nNew York State Medicaid Billing Guidelines for Administering Mental\nHealth or Substance Use Disorder Treatment Injections at the\nPharmacy and Record Document and Retention\nEffective April 1, 2024, in accordance with the amendments to §6801 and §6802 of Chapter 802 of the Laws\nof 2022, registered pharmacists, certified by the New York State (NYS) Education Department (ED) may\nadminister a long-acting injectable (LAI) approved by the Food and Drug Administration (FDA) for the\ntreatment of mental health or substance use disorder based on a patient specific prescription or order after\nthe initial injection was provided in the office of the practitioner.\nPolicy:\n• The certified pharmacist must confirm the initial injection has been given by the practitioner and the\nNYS Medicaid member is ready for maintenance therapy.\n• The NYS Medicaid member or the legally responsible representative of the NYS Medicaid member\nmust consent to the drug administration by a certified pharmacist.\n• The pharmacy must provide a private area for the drug administration. Ideally, the area should have\nseating, constructed to maximize auditory and visual privacy, and minimize barr", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0001", "char_start": 1050, "char_end": 2250, "pages": [1], "text": "rivate area for the drug administration. Ideally, the area should have\nseating, constructed to maximize auditory and visual privacy, and minimize barriers to communication.\n• The certified pharmacist must notify the prescriber of the NYS Medicaid member of the drug\nadministration, and if there were adverse reactions or any side effects.\nNotification must take place within five days via an interoperable electronic medical records\nsystem, electronic prescribing technology or pharmacy record, or other electronic transmission\nor facsimile. If electronic means are not available, the information may be communicated by\ntelephone.\nDocumentation\nThe following information must be documented and retained in the record of the pharmacy:\n• Contemporaneous records evidencing consent by NYS Medicaid member or representative to drug\nadministration by a certified pharmacist.\n• Confirmation that the initial injection has been given by the practitioner and the NYS Medicaid member\nis ready for maintenance therapy.\n• Date and time of the administration by the pharmacist.\nBilling Guidelines\nPharmacies will be reimbursed for the medication and an administration fee when billed to NYRx, the NYS\nMedicaid Ph", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0002", "char_start": 2100, "char_end": 3300, "pages": [1, 2], "text": "the pharmacist.\nBilling Guidelines\nPharmacies will be reimbursed for the medication and an administration fee when billed to NYRx, the NYS\nMedicaid Pharmacy program. The NYS Medicaid member will not have a copayment for drug administration.\nNYS legislation requires a patient specific prescription or order for administration. These orders must be\nkept on file at the pharmacy. If billing for both the drug and administration, these claims must be\nsubmitted separately.\nContinued on Page 3\n\nKathy Hochul\nGovernor\nState of New York\nJames McDonald, M.D., M.P.H.\nCommissioner\nNew York State\nDepartment of Health\nAmir Bassiri\nMedicaid Director\nOffice of Health Insurance Programs\nThe Medicaid Update is a monthly publication of the New York State Department of Health.\nIn This Issue…\nNew York State Medicaid Billing Guidelines for Administering Mental Health\nor Substance Use Disorder Treatment Injections at the Pharmacy and Record Documentation and Retention ...... Cover\nPolicy and Billing\nNew York State Medicaid Fee-for-Service Covers Adult Vaccinations Without Cost-Sharing .......................................... 3\nPractitioner Administered Drug Update: Brixadi™ Billing Guidance ..............", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0003", "char_start": 3150, "char_end": 4350, "pages": [2, 3], "text": "ions Without Cost-Sharing .......................................... 3\nPractitioner Administered Drug Update: Brixadi™ Billing Guidance .................................................................................. 4\nReminder: Compound Policy .............................................................................................................................................. 6\nNYRx Coverage Policy and Billing Guidance\nfor Pharmacist Dispensing of Self-Administered Hormonal Contraception ...................................................................... 10\nNew Medicaid Enrollment Option for Non-Enrolled Providers Seeking Medicare Bad Debt ........................................... 12\nProvider Directory ............................................................................................................................................................. 14\nApril 2024 New York State Medicaid Update pg. 2\n\nPolicy and Billing\nFor the drug, the claim must be submitted using the National Provider Identifier (NPI) of the ordering prescriber\nin the Prescriber ID field. The pharmacy will be reimbursed for the medication when billed via National Drug\nCode (NDC) using rei", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0004", "char_start": 4200, "char_end": 5400, "pages": [3], "text": " ordering prescriber\nin the Prescriber ID field. The pharmacy will be reimbursed for the medication when billed via National Drug\nCode (NDC) using reimbursement methodology. For the administration, the claim must be submitted using\nprocedure code “96372” and the pharmacy NPI in the Prescriber ID field. A pharmacy will be reimbursed\nthe administration fee of $13.36.\nQuestions and Additional Information:\n• Pharmacists should refer to the NYSED “Pharmacists” web page, located at: https://www.op.\nnysed.gov/pharmacist, for additional information.\n• NYRx claim questions should be directed to the eMedNY Call Center at (800) 343-9000.\n• NYRx Pharmacy coverage and policy questions should be directed to the NYS Medicaid Pharmacy\nPolicy Unit by telephone at (518) 486-3209 or by email at NYRx@health.ny.gov.\n***************************************************************************************************************\nNew York State Medicaid Fee-for-Service Covers\nAdult Vaccinations Without Cost-Sharing\nNew York State (NYS) Medicaid covers vaccines and their administration, without cost-sharing obligations,\nfor any outpatient clinic visit in which an approved adult vaccine, recommended by the A", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0005", "char_start": 5250, "char_end": 6450, "pages": [3], "text": "s and their administration, without cost-sharing obligations,\nfor any outpatient clinic visit in which an approved adult vaccine, recommended by the Advisory Committee\non Immunization Practices (ACIP), was administered as part of the visit.\nBilling Instructions for Fee-for-Service\nThe eMedNY system has been modified to systematically bypass all NYS Medicaid member cost-sharing\nrequirements for any outpatient clinic visits in which an approved adult vaccine, recommended by the ACIP,\nwas administered and no payment reduction will occur. Clinics no longer need to append modifier \"33\" to\nthe applicable Current Procedural Terminology (CPT)/Healthcare Common Procedure Coding System\n(HCPCS) code for the ACIP-recommended vaccine when submitting an outpatient Ambulatory Patient Group\n(APG) or Ordered Ambulatory claim to NYS Medicaid.\nQuestions and Additional Information:\n• Fee-for-service (FFS) billing and claim questions should be directed to the eMedNY Call Center at\n(800) 343-9000.\n• NYS Medicaid FFS medical coverage and policy questions should be directed to the Office of Health\nInsurance Programs (OHIP) Division of Program Development and Management (DPDM) by\ntelephone at (518) 473-216", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0006", "char_start": 6300, "char_end": 7500, "pages": [3, 4], "text": "ould be directed to the Office of Health\nInsurance Programs (OHIP) Division of Program Development and Management (DPDM) by\ntelephone at (518) 473-2160 or by email at FFSMedicaidPolicy@health.ny.gov.\n***************************************************************************************************************\nApril 2024 New York State Medicaid Update pg. 3\n\nPractitioner Administered Drug Update:\nBrixadi™ Billing Guidance\nEffective April 1, 2024, for New York State (NYS) Medicaid fee-for-service (FFS), practitioners must submit\na claim for BrixadiTM with a unit of “1” when the drug is administered in a medical office. The Centers for\nMedicare and Medicaid Services (CMS) has categorized Brixadi™ with reimbursement rates by the unit, not\nmilligrams or milliliters. A set rate has been established for the Healthcare Common Procedure Coding\nSystem (HCPCS) codes below:\n• “J0577” – “Injection, buprenorphine extended-release (Brixadi™), less than or equal to seven days\nof therapy.\"\n• “J0578” – “Injection, buprenorphine extended-release (Brixadi™), greater than seven days and up to\n28 days of therapy.\"\nBilling Units Clarification\nProviders should refer to the examples provided below to assi", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0007", "char_start": 7350, "char_end": 8550, "pages": [4, 5], "text": "di™), greater than seven days and up to\n28 days of therapy.\"\nBilling Units Clarification\nProviders should refer to the examples provided below to assist in completing the electronic Provider Assisted\nClaim Entry System (ePACES) electronic form or the Medical Assistance Health Insurance Claim Form\n(eMedNY 150003 form). Please note: When completing sections pertaining to National Drug Code (NDC),\nall formulations of BrixadiTM must be submitted with a value of “1” as the HCPCS unit quantity and the\nvolumetric quantity administered in milliliters.\nElectronic Claim Example for BrixadiTM Weekly 32mg/0.64ml Syringe\nJ0577 1\n58284023201\n1 -> milliliters\nApril 2024 New York State Medicaid Update pg. 4\n\n150003 Paper Claim Example for BrixadiTM Weekly 32mg/0.64ml Syringe\nWhen completing the Medical Assistance Health Insurance Claim Form (eMedNY 150003 form) for BrixadiTM,\nproviders should refer to the following instructions:\n1. Field 20: National Drug Code\nThe 11-digit unique identifier of the drug administered.\n2. Field 20A: Unit\nThe NDC unit of measure. All claims for BrixadiTM will be entered as milliliters or “ml”.\n3. Field 20B: Quantity\nEnter the volumetric quantity in milliliters in this", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0008", "char_start": 8400, "char_end": 9600, "pages": [5, 6], "text": " measure. All claims for BrixadiTM will be entered as milliliters or “ml”.\n3. Field 20B: Quantity\nEnter the volumetric quantity in milliliters in this field.\n4. 24C: Procedure Code\nThe primary five-digit HCPCS code.\n5. 24I: Days or Units\nEnter a value of “1” for all BrixadiTM claims.\nApril 2024 New York State Medicaid Update pg. 5\n\nQuestions and Additional Information:\n• Practitioners should refer to the ePACES Professional Real Time Claim Reference Guide, located at:\nhttps://www.emedny.org/selfhelp/ePACES/PDFS/5010_ePACES_Professional_Real_Time_Claim_R\neference_Guide.pdf, for additional information.\n• FFS billing and claim questions should be directed to the eMedNY Call Center at (800) 343-9000.\n• FFS provider billing guidance can be found in the eMedNY New York State 150003 Billing Guidelines\n– Physicians, located at: https://www.emedny.org/ProviderManuals/Physician/PDFS/Physician\n_Billing_Guidelines.pdf, and in the Policy and Billing Guidance Ambulatory Patient Groups (APGs)\nProvider Manual, located at: https://www.health.ny.gov/health_care/medicaid/rates/apg/docs/apg\n_provider_manual.pdf.\n• Practitioners should refer to the Clarification of Previous Guidance: New York State Med", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0009", "char_start": 9450, "char_end": 10650, "pages": [6], "text": "alth_care/medicaid/rates/apg/docs/apg\n_provider_manual.pdf.\n• Practitioners should refer to the Clarification of Previous Guidance: New York State Medicaid Fee-for-\nService Coverage of Practitioner Administered Drugs article published in the July 2022 issue of the\nMedicaid Update, located at: https://www.health.ny.gov/health_care/medicaid/program/update/2022/\ndocs/mu_no8_jul22_pr.pdf, for additional information.\n***************************************************************************************************************\nReminder: Compound Policy\nThis guidance is a reminder for pharmacies regarding compound prescription medications billed to New York\nState (NYS) Medicaid. Pharmacies must follow the compound policy as updated and previously\ncommunicated in the following Medicaid Update articles:\n• Compound Coverage Clarification article published in the August 2022 issue of the Medicaid Update,\nlocated at: https://www.health.ny.gov/health_care/medicaid/program/update/2022/docs/mu_no9_aug\n22_pr.pdf;\n• Update on Pharmacy Billing for Compound Prescriptions article published in the March 2022 issue of\nthe Medicaid Update, located at: https://www.health.ny.gov/health_care/medicaid/progr", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0010", "char_start": 10500, "char_end": 11700, "pages": [6], "text": "pound Prescriptions article published in the March 2022 issue of\nthe Medicaid Update, located at: https://www.health.ny.gov/health_care/medicaid/program/update/\n2022/docs/mu_no3_mar22_pr.pdf;\n• Compound Policy: A Reminder and Clarification article published in the December 2020 issue of the\nMedicaid Update, located at: https://www.health.ny.gov/health_care/medicaid/program/update/2020/\ndocs/mu_no18_dec20_pr.pdf; and\n• Update on Medicaid Fee-for-Service Prior Authorization of Topical Compounded Drug Products article\npublished in the November 2018 issue of the Medicaid Update, located at: https://www.health.ny.gov\n/health_care/medicaid/program/update/2018/nov18_mu.pdf.\nNYS Medicaid Compound Policy\nNYS Medicaid acknowledges the need for traditional extemporaneous compounding to customize a drug\nprescribed for a NYS Medicaid covered medically accepted indication which the therapeutic amounts,\ncombinations, and route of administration are Federal Drug Bureau (FDA) approved or compendia supported\nand there are no suitable commercially available products within the drug class. The Medicaid compound\npolicy is as follows:\n• Only the dispensing pharmacy may prepare the prescribed compounded ", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0011", "char_start": 11550, "char_end": 12750, "pages": [6, 7], "text": "able products within the drug class. The Medicaid compound\npolicy is as follows:\n• Only the dispensing pharmacy may prepare the prescribed compounded prescription.\n• Dispensing outsourced prepared compounds is not allowable.\n• Compounds trademarked by pharmacies are not coverable.\n• Refills of compounds must be specifically requested by the patient or the authorized agent of the\npatient before the item is prepared and submitted for payment.\n• Food and Drug Administration (FDA)-approved ingredients; or ingredients on the 503A FDA bulk list\nunder Category 1, submitted on compound claim; must be available on the eMedNY “Medicaid\nPharmacy List of Reimbursable Drugs” web page, located at: https://www.emedny.org\n/info/formfile.aspx.\nApril 2024 New York State Medicaid Update pg. 6\n\n• Compounds may not contain excluded drugs or be made for NYS Medicaid excluded indications as\nper the Social Security Act §1927(d)(2), located at: https://www.ssa.gov/OP_Home/ssact/title\n19/1927.htm, including, but not limited to drugs to treat weight loss or sexual dysfunction or for\ncosmetic purposes.\n• Compounds may not be made to bypass the criteria within the NYRx, the Medicaid Pharmacy Program\nPreferred ", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0012", "char_start": 12600, "char_end": 13800, "pages": [7], "text": "ual dysfunction or for\ncosmetic purposes.\n• Compounds may not be made to bypass the criteria within the NYRx, the Medicaid Pharmacy Program\nPreferred Drug List, located at: https://newyork.fhsc.com/downloads/providers/NYRx_PDP_PDL.pdf.\n• Compounds may not be made with or to replace drug products removed from the marketplace due to\nsafety reasons.\n• Compounds may not be made in therapeutic amounts or combinations not FDA-approved or\ncompendia-supported for use.\n• Compounds may not be made to add coloring, flavoring, perfumes, or other non-active ingredient\nadditives to a commercially available product.\n• Submitted compound claims may not include packaging materials or containers, syringes, or other\nitems utilized or necessary in the preparation or use of final compounded product.\n• Compounds must be adjudicated with the appropriate and matching final compounded product route\ncode for the dosage form.\n• Prepared compounds that mimic a commercial product must include on the prescription and in the\nmembers medical chart documentation of the reason for compounding (i.e., sensitivity or\ncontraindication to dyes, preservatives, or fillers or lack of availability of a commercial product).\n", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0013", "char_start": 13650, "char_end": 14850, "pages": [7], "text": "he reason for compounding (i.e., sensitivity or\ncontraindication to dyes, preservatives, or fillers or lack of availability of a commercial product).\n• The FDA-approved or compendia-supported use and dose of an ingredient must match the\ncompound´s intended therapeutic use.\n• Compounding kits packaged for convenience with premeasured ingredients are not covered as an\noutpatient drug per Social Security Act §1927(k)(2)(A)(i), located at: https://www.ssa.gov/OP_\nHome/ssact/title19/1927.htm, and Social Security Act §1902(a)(54), located at: https://www.ssa.gov/\nOP_Home/ssact/title19/1902.htm. Providers should refer to the billing section provided below for claim\nsubmission of individual ingredients.\n• Reconstitution per product labeling is not considered a compound whether it comes as a kit or requires\nadditional supplies, including those prepared for topical, oral, or parenteral use.\n• All NYS Medicaid policies, as well as NYS and federal laws, rules and regulations apply.\nThe NYS Department of Health (DOH) has made and will continually make formulary updates and system\nenhancements to support this policy. The Office of the Medicaid Inspector General (OMIG) will continue to\nreview cla", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0014", "char_start": 14700, "char_end": 15900, "pages": [7, 8], "text": "make formulary updates and system\nenhancements to support this policy. The Office of the Medicaid Inspector General (OMIG) will continue to\nreview claims for policy adherence.\nTopical\nExamples of non-covered topical compound claim submissions are those made with ingredients which are\nnot FDA-approved, compendia-supported or excluded from NYS Medicaid coverage for topical use, including\nbut not limited to:\n• anticonvulsants;\n• non-steroidal anti-inflammatory drugs (NSAIDS);\n• skeletal muscle relaxants;\n• combinations of two or more antifungals;\n• foot baths or soaks;\n• other soaks; or\n• irrigations.\nOral\nExamples of non-covered oral compound claim submissions are those made:\n• with ingredients not FDA-approved, compendia-supported for oral use or excluded from NYS Medicaid\ncoverage; or\n• by reconstituting commercially available products; or\n• as an enteral nutrition product.\nApril 2024 New York State Medicaid Update pg. 7\n\nProviders can refer to the correct billing guidance for these products in the eMedNY Medical Supplies\nProcedure Codes and Coverage Guidelines, located at: https://www.emedny.org/ProviderManuals/DME\n/PDFS/MedicalSupply_Procedure_Codes.pdf.\nParenteral\nExamples of no", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0015", "char_start": 15750, "char_end": 16950, "pages": [8], "text": "des and Coverage Guidelines, located at: https://www.emedny.org/ProviderManuals/DME\n/PDFS/MedicalSupply_Procedure_Codes.pdf.\nParenteral\nExamples of non-acceptable parenteral compound claim submissions are those:\n• inconsistent with sterile compound criteria as required by State or federal law or regulation [Title 8 of\nthe New York Codes, Rules and Regulations (NYCRR) Part 29.2 (13), located at: https://\nwww.op.nysed.gov/title8/rules-board-regents/part-29], or\n• made to simply dilute, reconstitute, or otherwise prepare a medication for infusion per its labeling, or\n• products made for nutrition or hydration.\nProviders can refer to the correct billing guidance for these products in the eMedNY Medical Supplies\nProcedure Codes and Coverage Guidelines, located at: https://www.emedny.org/ProviderManuals/\nDME/PDFS/MedicalSupply_Procedure_Codes.pdf.\nPharmacy Billing\nPer NYS Medicaid policy, when billing a compound via National Council for Prescription Drug Programs\n(NCPDP) D.0 transaction, providers must submit a minimum of two ingredients [or National Drug Codes\n(NDCs)] in the Compound Segment, field 489-TE (Compound Product ID). Providers can submit up to 25\nNDCs using this field. Provid", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0016", "char_start": 16800, "char_end": 18000, "pages": [8], "text": "r National Drug Codes\n(NDCs)] in the Compound Segment, field 489-TE (Compound Product ID). Providers can submit up to 25\nNDCs using this field. Providers must also submit a compound code of \"02-Compound\" in field 406-D6\n(Compound Code) in the Claim Segment. Claims with NDCs listed in the Compound Segment submitted as\na compound code \"01-Not a compound\" will not be accepted. All compound claims must include a valid\nRoute of Administration code using terminology from the Systematized Nomenclature of Medicine–Clinical\nTerms (SNOMED–CT) in NCPDP field 995-E2. All ingredients of a compounded prescription must be\nsubmitted to NYS Medicaid regardless of reimbursement.\neMedNY Edit Number/Message NCPDP Response Code/Description\n70420 – Compound Segment found when 8D – Compound Segment present on a non-\ncompound drug code is not compound compound claim\nCompound-Only Ingredients\nItems intended for compound use only, such as suspending agents or bulk powders, may only be reimbursed\nas part of a compound claim. These items will not be reimbursed when submitted as a single ingredient claim\nand will deny when compound code \"01-Not a compound\" is submitted in field 406-D6 (Compound Code)\nin the cl", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0017", "char_start": 17850, "char_end": 19050, "pages": [8, 9], "text": "hen submitted as a single ingredient claim\nand will deny when compound code \"01-Not a compound\" is submitted in field 406-D6 (Compound Code)\nin the claim segment.\neMedNY Edit Number/Message NCPDP Response Code/Description\n02326 – Drug only covered in compound 8D – Product/service only covered on compound claim\nNon-Reimbursable Ingredients\nPayment will only be issued for drugs found on the eMedNY “Medicaid Pharmacy List of Reimbursable Drugs”\nweb page, located at: https://www.emedny.org/info/formfile.aspx. If an ineligible drug or drug product is\nincluded in the compound, the claim will deny. The pharmacy provider may then elect to receive payment\nonly for those reimbursable drugs by resubmitting the claim with of \"08-Process Compound for Approved\nIngredients\" in field 420-DK (Submission Clarification Code) when all other coverage criteria is met. Please\nnote: Submission Clarification Code of \"08\" should only be utilized in accordance with NYS Medicaid policy.\nThe NYS DOH will monitor the use of these codes.\nApril 2024 New York State Medicaid Update pg. 8\n\nPrior Authorization\nPer the September 2015 NYS Medicaid Drug Utilization Review (DUR) Board recommendations, located at:\nhttps:/", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0018", "char_start": 18900, "char_end": 20100, "pages": [8, 9], "text": "edicaid Update pg. 8\n\nPrior Authorization\nPer the September 2015 NYS Medicaid Drug Utilization Review (DUR) Board recommendations, located at:\nhttps://www.health.ny.gov/health_care/medicaid/program/dur/meetings/2015/09/summary_durb.pdf, and the\nUpdate on Medicaid Fee-for-Service Prior Authorization of Topical Compounded Drug Products article\npublished in the November 2018 issue of the Medicaid Update, located at: https://www.health\n.ny.gov/health_care/medicaid/program/update/2018/nov18_mu.pdf, prior authorization (PA) and editing on\nprescriptions for all topical compounded drug products is required and will be implemented on certain NYRx\nMedicaid fee-for-service (FFS) claims. This process will ensure that compounded topical drug products meet\nState and Federal regulations and that the compound ingredients are FDA-approved or compendia-supported\nfor topical use when submitted to NYRx.\nPharmacies that submit topical compounds may receive the following edits:\n• Edit “02282” – NCPDP code “75”, PA Required Call Magellan. This is specific to topical compounds.\n• Edit “02283” – NCPDP code “E2”, Missing Invalid (M/I) Route of Administration. NCPDP field 995-\nE2 (Route of Administration) wi", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0019", "char_start": 19950, "char_end": 21150, "pages": [9], "text": "o topical compounds.\n• Edit “02283” – NCPDP code “E2”, Missing Invalid (M/I) Route of Administration. NCPDP field 995-\nE2 (Route of Administration) will be required for any topical compound claim.\nTo obtain a PA, the prescriber must contact the PA clinical call center at (877) 309-9493. The PA clinical call\ncenter is available 24 hours per day, seven days per week with pharmacy technicians and pharmacists who\nwill work with prescribers or the prescriber agent to quickly obtain a PA.\nQuestions and Additional Information:\n• The 503A FDA bulk agent list can be found on the FDA “Bulk Drug Substances Used in Compounding\nUnder Section 503A of the FD&C Act” web page, at: https://www.fda.gov/drugs/human-drug-\ncompounding/bulk-drug-substances-used-compounding-under-section-503a-fdc-act.\n• Medicaid Update articles regarding compounding and other topics can be found on the NYS DOH\nMedicaid Update homepage, located at: https://www.health.ny.gov/health_care/medicaid/program\n/update/main.htm.\n• A list of reimbursable NYS Medicaid drugs can be found on the eMedNY “Medicaid Pharmacy List of\nReimbursable Drugs” web page, located at: https://www.emedny.org/info/formfile.aspx.\n• A list of drugs in th", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0020", "char_start": 21000, "char_end": 22200, "pages": [9, 10], "text": " on the eMedNY “Medicaid Pharmacy List of\nReimbursable Drugs” web page, located at: https://www.emedny.org/info/formfile.aspx.\n• A list of drugs in the NYRx Pharmacy Programs can be found in the NYRx, the Medicaid Pharmacy\nProgram Preferred Drug List, located at: https://newyork.fhsc.com/downloads/providers/NYRx_PDP_\nPDL.pdf.\n• Questions regarding compound billing should be directed to the eMedNY Call Center at (800) 343-\n9000.\n• Questions regarding this policy should be directed to the NYRx by telephone at (518) 486-3209 or by\nemail at NYRx@health.ny.gov.\n• Medicaid Managed Care (MMC) enrollee claims, regardless of claim type, pharmacy or medical, are\nalso subject to the requirements above. Any questions, including as to MMC reimbursement, billing,\nand/or documentation requirements should be directed to the MMC Plan of the enrollee.\n***************************************************************************************************************\nApril 2024 New York State Medicaid Update pg. 9\n\nNYRx Coverage Policy and Billing Guidance for Pharmacist\nDispensing of Self-Administered Hormonal Contraception\nChapter 128 of the Laws of 2023, as amended by Chapter 90 of the Laws of 2024, am", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0021", "char_start": 22050, "char_end": 23250, "pages": [10], "text": "or Pharmacist\nDispensing of Self-Administered Hormonal Contraception\nChapter 128 of the Laws of 2023, as amended by Chapter 90 of the Laws of 2024, amends New York State\n(NYS) Education Law to allow pharmacists licensed and located in NYS to dispense self-administered\nhormonal contraceptives pursuant to a non-patient specific order written by the Commissioner of Health\n(COH), a physician-licensed, or a nurse practitioner (NP) certified in NYS.\nSelf-administered hormonal contraceptives means self-administered contraceptive medications or devices\napproved by the Food and Drug Administration (FDA) to prevent pregnancy by using hormones to regulate\nor prevent ovulation, and includes oral hormonal contraceptives, hormonal contraceptive vaginal rings and\nhormonal contraceptive patches. When used correctly, the medications and devices are 99 percent effective\nat preventing pregnancy.\nThe COH is authorized by Public Health Law §267-a, located at: https://www.nysenate.gov/legislation\n/laws/PBH/267-A, to establish a non-patient specific order for pharmacists’ dispensing of self-administered\nhormonal contraception. As described in the standing order, sufficient clinical information should be\n", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0022", "char_start": 23100, "char_end": 24300, "pages": [10], "text": "or pharmacists’ dispensing of self-administered\nhormonal contraception. As described in the standing order, sufficient clinical information should be\ndocumented in the profile of the patient when self-administered hormonal contraceptives are dispensed\nby a state-licensed pharmacist. Pharmacists dispensing self-administered hormonal contraceptives\nmust retain documentation that includes:\n• NYS Medicaid member request for services;\n• date, time, and duration of the encounter;\n• if the NYS Medicaid member is a new or existing patient;\n• NYS Medicaid member completed New York State Department of Health DOH CONTRACEPTION:\nSelf-Screening Patient Intake Form, located at: https://health.ny.gov/community/reproductive_health/\ndocs/self_screening_questionnaire.pdf (this form documents NYS Medicaid member consent);\n• the result of the clinical decision utilizing the New York State Department of Health\nCONTRACEPTION: Standardized Assessment and Treatment Care Pathway document, located at:\nhttps://www.health.ny.gov/community/reproductive_health/docs/self_screening_workflow.pdf; and\n• if applicable, date and time communication sent to the primary care provider of the individual.\nNYRx Pharmacy Bil", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0023", "char_start": 24150, "char_end": 25350, "pages": [10], "text": "s/self_screening_workflow.pdf; and\n• if applicable, date and time communication sent to the primary care provider of the individual.\nNYRx Pharmacy Billing:\n• To bill for the self-administered hormonal contraception, the pharmacy must submit a valid National\nDrug Code (NDC). Pharmacies must bill the Usual and Customary (U&C) price and will be reimbursed\naccording to NYRx payment methodology and a $10.18 dispensing fee.\n• To bill for the evaluation and management (E&M) associated with the dispensing of self-administered\nhormonal contraception, pharmacies will submit using the National Council for Prescription Drug\nPrograms (NCPDP) D.0 claim format and enter one of the Healthcare Common Procedure Coding\nSystem (HCPCS) codes identified below.\n• NYRx members may receive up to 12 months of prescription contraceptives at one time for family\nplanning purposes as authorized by Title 18 of the New York Codes, Rules and Regulations (NYCRR)\n§505.3(e), located at: https://regs.health.ny.gov/content/section-5053-drugs.\n• Pharmacies are expected to dispense up to the quantity limit of the prescription or Standing Order,\none year supply, at the time of dispensing, pursuant to patient preference or", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0024", "char_start": 25200, "char_end": 26400, "pages": [10, 11], "text": "dispense up to the quantity limit of the prescription or Standing Order,\none year supply, at the time of dispensing, pursuant to patient preference or primary insurance\ncoverage limitations.\n• Submitting any assessment code more than once a year requires cause.\nApril 2024 New York State Medicaid Update pg. 10\n\nBilling Instructions for Self-Administered Hormonal Contraception\nNCPDP D.0. Claim Segment Field Value\n436-E1 (Product/Service ID Qualifier) Enter a value of \"03\" (NDC).\n444-E9 (Pharmacist ID) Enter pharmacist National Provider\nIdentifier (NPI) number.\n411-DB (Prescriber ID) Enter prescriber NPI number.\nBilling Instructions for E&M Related to Pharmacist Dispensing of Contraception\nA state-licensed pharmacist dispensing self-administered hormonal contraceptives may enter one of the\nfollowing HCPCS codes when performing E&M of a NYRx member:\nHCPCS Value Fee\nCode\n99605* Medication therapy management service(s) provided by a pharmacist, individual, face- $48.20\nto-face with patient, with assessment and intervention if provided; 15 minutes, new\npatient.\n99606** Medication therapy management service(s) provided by a pharmacist, individual, face- $15.29\nto-face with patient, with as", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0025", "char_start": 26250, "char_end": 27450, "pages": [11], "text": "inutes, new\npatient.\n99606** Medication therapy management service(s) provided by a pharmacist, individual, face- $15.29\nto-face with patient, with assessment and intervention if provided; 15 minutes,\nestablished patient.\n*A patient would be considered a \"new patient\" when pharmacist is conducting the initial assessment for self- administered hormonal\ncontraceptives.\n**A patient would be considered an \"established patient\" for subsequent assessments that occur after their initial assessment has\nbeen completed.\nThe above HCPCS codes may be submitted in the NCPDP D.0 format, as outlined below:\nNCPDP D.0 Claim Segment Field Value\n436-E1 (Product/Service ID Qualifier) Enter the applicable value, which qualifies the code submitted in\nfield 407-D7 (Product/Service ID) as a procedure code.\n407-D7 (Product/Service ID) Enter the value of \"99605\" if prescribing for a new patient.\nEnter the value of \"99606\" if prescribing for an established\npatient.\n444-E9 (Pharmacist ID) Enter the pharmacist NPI number.\n411-DB (Prescriber ID) Enter the pharmacy NPI number.\nProviders must refer to the NYRx the NY Medicaid Pharmacy Program – Pharmacy Manual Policy Guidelines,\nlocated on the eMedNY “Pharmacy Ma", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0026", "char_start": 27300, "char_end": 28500, "pages": [11], "text": " NPI number.\nProviders must refer to the NYRx the NY Medicaid Pharmacy Program – Pharmacy Manual Policy Guidelines,\nlocated on the eMedNY “Pharmacy Manual” web page, at: https://www.emedny.org/ProviderManuals/\nPharmacy/, for further guidance on origin code and serial number values that must be submitted on the claim.\nProviders may only submit claims for payment for furnished services in which were medically\nnecessary [Title 18 of the NYCRR 504.3(e), located at: https://regs.health.ny.gov/content/section-5043-\nduties-provider]. All claims are subject to audit and recovery.\nQuestions and Additional Information:\n• For COH Standing Orders, forms, fact sheets and program information, providers should refer to the\nNYS DOH “Reproductive Health” web page, located at: https://www.health.ny.gov/community/\nreproductive_health/.\n• Pharmacists should refer to the NYSED “Pharmacists” web page, located at: https://www.op.nysed\n.gov/pharmacist, for additional information.\n• NYRx billing questions should be directed to the eMedNY Call Center at (800) 343-9000.\n• NYRx pharmacy coverage and policy questions should be directed to the Medicaid Pharmacy Policy\nUnit by telephone at (518) 486-3209 or by e", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0027", "char_start": 28350, "char_end": 29550, "pages": [11, 12], "text": "343-9000.\n• NYRx pharmacy coverage and policy questions should be directed to the Medicaid Pharmacy Policy\nUnit by telephone at (518) 486-3209 or by email at NYRx@health.ny.gov.\n***************************************************************************************************************\nApril 2024 New York State Medicaid Update pg. 11\n\nNew Medicaid Enrollment Option\nfor Non-Enrolled Providers Seeking Medicare Bad Debt\nThe Centers for Medicare and Medicaid Services (CMS) amended 42 Code of Federal Regulations (CFR)\n§455.410(d), located at: https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-C/part-455/subpart-\nE/section-455.410, to reduce the number of Medicare bad debt appeals. The CMS Final Rule requires\nMedicare-enrolled non-institutional providers and suppliers seeking to claim Medicare bad debt to enroll in a\nState’s Medicaid program for the sole purpose of receiving a zero-dollar Medicaid Remittance Advice (RA).\nTo comply with the CMS Final Rule, New York State (NYS) Medicaid has implemented two new provider\nenrollment categories of service (COS).\nBackground\n42 CFR §455.410 was amended to codify Medicare’s longstanding “must-bill” policy outlined in 42 CFR\n§413.89 – ", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0028", "char_start": 29400, "char_end": 30600, "pages": [12], "text": "categories of service (COS).\nBackground\n42 CFR §455.410 was amended to codify Medicare’s longstanding “must-bill” policy outlined in 42 CFR\n§413.89 – Bad debts, charity, and courtesy allowances, located at: https://www.ecfr.gov/current/title-\n42/chapter-IV/subchapter-B/part-413/subpart-F/section-413.89. In the past, State Medicaid programs have\nconstrained and/or prevented enrollment of certain types of providers or suppliers that are not explicitly\nincluded in their State Plan. Medicare-enrolled provider/suppliers that are unable to enroll in a State Medicaid\nprogram cannot have their cost-sharing claims adjudicated in the State Medicaid Management Information\nSystem (MMIS) nor obtain a Medicaid RA.\nThis amendment requires the state Medicaid agency to allow enrollments of Medicare-enrolled\nproviders/suppliers meet all federal Medicaid enrollment requirements, including, but not limited to, all\napplicable provisions of 42 CFR §455, subparts B and E, located at: https://www.ecfr.gov/current/title-\n42/chapter-IV/subchapter-C/part-455?toc=1, where such enrollments are solely for the purpose of processing\nclaims to determine Medicare cost-sharing, as defined in §1905(p)(3) of the Socia", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0029", "char_start": 30450, "char_end": 31650, "pages": [12], "text": "c=1, where such enrollments are solely for the purpose of processing\nclaims to determine Medicare cost-sharing, as defined in §1905(p)(3) of the Social Security Act, located at:\nhttps://www.ssa.gov/OP_Home/ssact/title19/1905.htm. This provision does not require States to enroll\nprovider types not recognized by their Medicaid program for purposes other than the submission of Medicare\ncost-sharing claims, adjudication of such claims, and issuance of a Medicaid RA.\nProvider Enrollment\nMedicare providers/suppliers who are only seeking a zero-dollar RA to claim Medicare bad debt must choose\nthis Medicare Cost-Sharing Only option for NYS Medicaid enrollment. This includes Medicare-enrolled\nproviders/suppliers who are currently recognized by the NYS Medicaid program (i.e., enrollable, but who wish\nto engage the NYS Medicaid program for the sole purpose of submitting claims for Medicare cost-sharing to\nobtain a zero-dollar RA).\nProviders interested in enrolling under one of the newly created COS should visit the relevant link below for\nadditional information:\n• Medicare-enrolled business/group providers or suppliers (COS “0630”): eMedNY “Provider\nEnrollment and Maintenance – Medicare Cost ", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0030", "char_start": 31500, "char_end": 32700, "pages": [12, 13], "text": "onal information:\n• Medicare-enrolled business/group providers or suppliers (COS “0630”): eMedNY “Provider\nEnrollment and Maintenance – Medicare Cost Sharing business” web page, located at: https://www\n.emedny.org/info/ProviderEnrollment/misc_business/.\n• Medicare-enrolled individual practitioners (COS “0631”): eMedNY “Provider Enrollment and\nMaintenance – Medicare Cost Sharing Practitioner” web page, located at: https://www.emedny\n.org/info/ProviderEnrollment/misc_practitioner/.\nPlease note: Billing, rendering/attending, and ordering/referring providers who are reported on Medicare\ncost-sharing-only claim submissions must also be enrolled in Medicaid under either a Medicare Cost-Sharing\nOnly COS or as a Medicaid provider under a COS already recognized by the State plan.\nApril 2024 New York State Medicaid Update pg. 12\n\nClaim Submission\nClaims submitted to Medicaid containing a billing provider assigned a Medicare Cost-Sharing Only COS will\nreturn a zero liability/zero payment RA back to the billing provider. Medicare must be reported as primary on\nthese claim submissions.\nQuestions and Additional Resources:\n• Fee-for-service (FFS) claims reimbursement, and/or provider enrollment q", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0031", "char_start": 32550, "char_end": 33750, "pages": [13, 14], "text": " as primary on\nthese claim submissions.\nQuestions and Additional Resources:\n• Fee-for-service (FFS) claims reimbursement, and/or provider enrollment questions should be directed\nto the eMedNY Call Center by telephone at (800) 343-9000 or by visiting the eMedNY homepage,\nlocated at: https://www.emedny.org/, for additional information.\n• FFS coverage and policy questions should be directed to the Office of Health Insurance Programs\n(OHIP) Division of Program Development and Management (DPDM) by telephone at (518) 473-2160\nor by email at FFSMedicaidPolicy@health.ny.gov.\n***************************************************************************************************************\nApril 2024 New York State Medicaid Update pg. 13\n\nProvider Directory\nOffice of the Medicaid Inspector General:\nFor suspected fraud, waste, or abuse complaints/allegations, please call 1-877-87 FRAUD, (877) 873-7283,\nor visit the Office of Medicaid Inspector General (OMIG) web site at: www.omig.ny.gov.\nProvider Manuals/Companion Guides, Enrollment Information/Forms/Training Schedules:\nPlease visit the eMedNY website at: www.emedny.org.\nProviders wishing to listen to the current week’s check/EFT amounts:\nPlease", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0032", "char_start": 33600, "char_end": 34800, "pages": [14], "text": "ms/Training Schedules:\nPlease visit the eMedNY website at: www.emedny.org.\nProviders wishing to listen to the current week’s check/EFT amounts:\nPlease call (866) 307-5549 (available Thursday PM for one week for the current week's amount).\nFor questions about billing and performing MEVS transactions:\nPlease call the eMedNY Call Center at (800) 343-9000.\nProvider Training:\nPlease enroll online for a provider seminar at: https://www.emedny.org/training/index.aspx. For individual\ntraining requests, please call (800) 343-9000.\nBeneficiary Eligibility:\nPlease call the Touchtone Telephone Verification System at (800) 997-1111.\nMedicaid Prescriber Education Program:\nFor current information on best practices in pharmacotherapy, please visit the following web sites:\n• DOH Prescriber Education Program page:\nhttps://www.health.ny.gov/health_care/medicaid/program/prescriber_education/presc-educationprog.\n• Prescriber Education Program in partnership with SUNY: http://nypep.nysdoh.suny.edu/.\neMedNY\nFor a number of services, including: change of address, updating an enrollment file due to an ownership\nchange, enrolling another NPI, or revalidating an existing enrollment, please visit the eMedNY P", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0033", "char_start": 34650, "char_end": 35117, "pages": [14], "text": "ress, updating an enrollment file due to an ownership\nchange, enrolling another NPI, or revalidating an existing enrollment, please visit the eMedNY Provider\nEnrollment page at: https://www.emedny.org/info/ProviderEnrollment/index.aspx, and choose the\nappropriate link based on provider type.\nComments and Suggestions Regarding This Publication\nPlease contact the editor, Angela Lince, at medicaidupdate@health.ny.gov.\nApril 2024 New York State Medicaid Update pg. 14", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0034", "char_start": 34967, "char_end": 35117, "pages": [14], "text": " Regarding This Publication\nPlease contact the editor, Angela Lince, at medicaidupdate@health.ny.gov.\nApril 2024 New York State Medicaid Update pg. 14", "chunk_type": "text", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0035::table", "char_start": null, "char_end": null, "pages": [8], "text": ",eMedNY Edit Number/Message,,,NCPDP Response Code/Description,\r\n\"70420 – Compound Segment found when\ncompound drug code is not compound\",,,\"8D – Compound Segment present on a non-\ncompound claim\",,\r\n", "chunk_type": "table", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0036::table", "char_start": null, "char_end": null, "pages": [8], "text": ",eMedNY Edit Number/Message,,,NCPDP Response Code/Description,\r\n02326 – Drug only covered in compound,,,8D – Product/service only covered on compound claim,,\r\n", "chunk_type": "table", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0037::table", "char_start": null, "char_end": null, "pages": [11], "text": ",NCPDP D.0. Claim Segment Field,,,Value,\r\n436-E1 (Product/Service ID Qualifier),,,\"Enter a value of \"\"03\"\" (NDC).\",,\r\n444-E9 (Pharmacist ID),,,\"Enter pharmacist National Provider\nIdentifier (NPI) number.\",,\r\n411-DB (Prescriber ID),,,Enter prescriber NPI number.,,\r\n", "chunk_type": "table", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0038::table", "char_start": null, "char_end": null, "pages": [11], "text": ",HCPCS,,Value,Fee\r\n,Code,,,\r\n99605*,,,\"Medication therapy management service(s) provided by a pharmacist, individual, face-\nto-face with patient, with assessment and intervention if provided; 15 minutes, new\npatient.\",$48.20\r\n99606**,,,\"Medication therapy management service(s) provided by a pharmacist, individual, face-\nto-face with patient, with assessment and intervention if provided; 15 minutes,\nestablished patient.\",$15.29\r\n", "chunk_type": "table", "category": "unknown"}
{"doc_id": "mu_no4_apr24_pr.pdf", "chunk_id": "mu_no4_apr24_pr.pdf::0039::table", "char_start": null, "char_end": null, "pages": [11], "text": ",NCPDP D.0 Claim Segment Field,,,Value,\r\n436-E1 (Product/Service ID Qualifier),,,\"Enter the applicable value, which qualifies the code submitted in\nfield 407-D7 (Product/Service ID) as a procedure code.\",,\r\n407-D7 (Product/Service ID),,,\"Enter the value of \"\"99605\"\" if prescribing for a new patient.\",,\r\n,,,\"Enter the value of \"\"99606\"\" if prescribing for an established\npatient.\",,\r\n444-E9 (Pharmacist ID),,,Enter the pharmacist NPI number.,,\r\n411-DB (Prescriber ID),,,Enter the pharmacy NPI number.,,\r\n", "chunk_type": "table", "category": "unknown"}
